PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT): key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$336.1K

Net Income/Loss (FY2025)

-$5.5M

Total Assets (FY2025)

$697.5K

Total Equity (FY2025)

-$6.3M

Cash Flows from Operating Activities (FY2025)

-$3.3M

Source: PROVECTUS BIOPHARMACEUTICALS, INC. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.